1. Market Research
  2. > Pharmaceutical Market Trends
  3. > Sweden Pharmaceuticals and Healthcare Report Q1 2016

Sweden Pharmaceuticals and Healthcare Report Q1 2016

  • November 2015
  • -
  • Business Monitor International
  • -
  • 92 pages

Includes 3 FREE quarterly updates

BMI View: We continue to view Sweden as a moderately attractive regional market. The proportion of thecountry's pensionable population is on the rise and coupled with high per capita spending, multinationalpharmaceutical companies will continue to be provided with steady revenue-earning opportunities. Suchdemographic trends will remain the primary driver of growth behind the prescription drug markets thoughwe highlight that the government is likely to put further emphasis on promoting cost-reduction initiativesthat would be supportive of the generic medicines market, which would see the market share of patentedmedicines weaken.

Headline Expenditure Projections

-Pharmaceuticals: SEK37.70bn (USD5.49bn) in 2014 to SEK37.83bn (USD4.38bn) in 2015; +0.34% inlocal currency terms and -20.3% in US dollar terms.
-Healthcare: SEK362.42bn (USD52.81bn) in 2014 to SEK371.82bn (USD43.05bn) in2015; +2.6% inlocal currency terms and -18.5% in US dollar terms.

Table Of Contents

Sweden Pharmaceuticals and Healthcare Report Q1 2016
BMI Industry View 7
Table: Headline Pharmaceuticals and Healthcare Forecasts (Sweden 2013-2019) 7
SWOT 9
Industry Forecast 11
Pharmaceutical Market Forecast 11
Table: Pharmaceutical Sales, Historical Data And Forecasts (Sweden 2011-2019) 13
Healthcare Market Forecast 14
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2011-2019) 16
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2011-2019) 16
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Sweden 2011-2019) 17
Prescription Drug Market Forecast 18
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Sweden 2011-2019) 19
Patented Drug Market Forecast 20
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Sweden 2011-2019) 21
Generic Drug Market Forecast 22
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Sweden 2011-2019) 23
OTC Medicines Market Forecast 24
Table: OTC Sales by Therapeutic Group At Retail Prices, 2009-2010 (SEKmn) 25
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Sweden 2011-2019) 26
Pharmaceutical Trade Forecast 27
Table: Pharmaceutical Trade Data And Forecasts (Sweden 2013-2019) 28
Table: Pharmaceutical Trade Data And Forecasts local currency (Sweden 2013-2019) 29
Industry Risk/Reward Index 30
Western Europe Risk/Reward Index 30
Sweden Risk/Reward Index 36
Rewards 36
Risks 36
Regulatory Review 38
Intellectual Property Issues 39
Pricing Regime 40
Reimbursement Regime 41
Market Overview 43
Healthcare Sector 43
Table: Healthcare Resources (Sweden 2009-2014) 46
Table: Healthcare Personnel (Sweden 2009-2014) 46
Table: Healthcare Activity (Sweden 2009-2014) 47
Research and Development 47
Table: Drug Development Member Companies of SwedenBIO, 2015 47
Clinical Trials 48
Epidemiology 49
Competitive Landscape 53
Research-Based Industry 53
Pharmaceutical Industry Developments 55
Table: Multinational Market Activity 55
Pharmaceutical Distribution 57
Pharmaceutical Retail Sector 58
Company Profile 60
AstraZeneca 60
Meda 65
Medivir 69
Novartis 73
Swedish Orphan Biovitrum (SOBI) 76
Demographic Forecast 81
Table: Population Headline Indicators (Sweden 1990-2025) 82
Table: Key Population Ratios (Sweden 1990-2025) 82
Table: Urban/Rural Population and Life Expectancy (Sweden 1990-2025) 83
Table: Population By Age Group (Sweden 1990-2025) 83
Table: Population By Age Group % (Sweden 1990-2025) 84
Glossary 86
Methodology 88
Pharmaceutical Expenditure Forecast Model 88
Healthcare Expenditure Forecast Model 88
Notes On Methodology 89
Risk/Reward Index Methodology 90
Index Overview 91
Table: Pharmaceutical Risk/Reward Index Indicators 91
Indicator Weightings 92

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024

  • $ 10995
  • Industry report
  • September 2016
  • by Global Data

PharmaPoint: Attention Deficit Hyperactivity Disorder (ADHD) - Global Drug Forecast and Market Analysis to 2024 Summary Attention deficit hyperactivity disorder (ADHD) is characterized by excessive levels ...

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

Global Pharmaceutical Contract Manufacturing Organization (CMO) Market

  • $ 7000
  • Industry report
  • August 2016
  • by Frost & Sullivan

Emerging Business Models Drive Transformation The key objective of this research is to provide in-depth knowledge of the major global pharmaceutical CMO market segments—active pharmaceutical ingredients ...

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation

  • $ 6995
  • Industry report
  • November 2016
  • by GBI Research

Frontier Pharma: Asthma Therapeutics - Cytokine and Kinase Targeted Small Molecules and mAbs Increase Pipeline Diversity and Dominate First-in-Class Innovation Summary Asthma is a chronic condition affecting ...


ref:plp2015

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.